Accession Number: | 0000899243-20-004902 |
Date: | 2020-02-14 |
Issuer: | CONSTELLATION PHARMACEUTICALS INC (CNST) |
Original Submission Date: |
TROJER PATRICK
C/O CONSTELLATION PHARMACEUTICALS, INC.
215 FIRST STREET, SUITE 200
CAMBRIDGE, MA 02142
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 36.06 | 2020-02-14 | deemed execution date | A | 55,000 (a) | 2030-02-13 | common stock 55,000 | $36.06 | 55,000 | direct |
ID | footnote |
---|---|
f1 | this option was granted on february 14, 2020, and the shares underlying the option vest in equal quarterly installments through february 14, 2024, subject to continued service. |